184 related articles for article (PubMed ID: 32337773)
1. Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation.
Senev A; Emonds MP; Van Sandt V; Lerut E; Coemans M; Sprangers B; Kuypers D; Naesens M
Am J Transplant; 2020 Dec; 20(12):3367-3378. PubMed ID: 32337773
[TBL] [Abstract][Full Text] [Related]
2. Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation.
Senev A; Lerut E; Van Sandt V; Coemans M; Callemeyn J; Sprangers B; Kuypers D; Emonds MP; Naesens M
Am J Transplant; 2019 Nov; 19(11):3100-3113. PubMed ID: 31062492
[TBL] [Abstract][Full Text] [Related]
3. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.
Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395
[TBL] [Abstract][Full Text] [Related]
5. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.
Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M
Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278
[TBL] [Abstract][Full Text] [Related]
6. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
7. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
9. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
Callemeyn J; Senev A; Coemans M; Lerut E; Sprangers B; Kuypers D; Koenig A; Thaunat O; Emonds MP; Naesens M
J Am Soc Nephrol; 2021 Aug; 32(8):2070-2082. PubMed ID: 34301794
[TBL] [Abstract][Full Text] [Related]
10. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies.
Haller J; Wehmeier C; Hönger G; Hirt-Minkowski P; Gürke L; Wolff T; Steiger J; Amico P; Dickenmann M; Schaub S
Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266
[TBL] [Abstract][Full Text] [Related]
11. High-resolution HLA genotyping improves PIRCHE-II assessment of molecular mismatching in kidney transplantation.
Crane C; Niemann M; Dale B; Gragert L; Shah M; Ingulli E; Morris GP
Hum Immunol; 2024 May; 85(3):110813. PubMed ID: 38749805
[TBL] [Abstract][Full Text] [Related]
12. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure.
Khovanova N; Daga S; Shaikhina T; Krishnan N; Jones J; Zehnder D; Mitchell D; Higgins R; Briggs D; Lowe D
Transpl Int; 2015 Dec; 28(12):1405-15. PubMed ID: 26264744
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
17. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
Wehmeier C; Hönger G; Cun H; Amico P; Hirt-Minkowski P; Georgalis A; Hopfer H; Dickenmann M; Steiger J; Schaub S
Am J Transplant; 2017 Aug; 17(8):2092-2102. PubMed ID: 28245084
[TBL] [Abstract][Full Text] [Related]
18. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact of HLA and MICA allele mismatching on donor-specific antibodies induction in kidney transplant rejection.
Romphruk AV; Simtong P; Suntornnipat J; Sudwilai Y; Cheunta S; Chan-On C; Leelayuwat C
Nephrology (Carlton); 2021 Oct; 26(10):833-841. PubMed ID: 34197005
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study.
Hachem RR; Kamoun M; Budev MM; Askar M; Ahya VN; Lee JC; Levine DJ; Pollack MS; Dhillon GS; Weill D; Schechtman KB; Leard LE; Golden JA; Baxter-Lowe L; Mohanakumar T; Tyan DB; Yusen RD
Am J Transplant; 2018 Sep; 18(9):2285-2294. PubMed ID: 29687961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
